@MSharifpourMD @HuzaifahSalat @Diana_Kelm @ELSOOrg @ECMOprincess @AvrahamCooperMD @Thind888 @laxswamy @sarahanifmirza @JonahRubinMD @efan75 Also - here's the link to the Lancet paper https://t.co/jCPBB4d50h
Extracorporeal membrane oxygenation support in COVID-19 (this was from https://t.co/Z3RbhYN0AS registry) https://t.co/lAPo607kS0 38-40% mortality (similar to other forms of ARDS), some rather obvious modifiers https://t.co/BotV2G2Wox
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
RT @SRAnesthesiaICU: Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is…
Initial reports from China showed poor outcomes in #VVECMO #COVID19 patients (mortality around 100%) But mortality is only 40% around the world!! Thanks to this large #lancet study to document it in over 1000 patients 3/7 @BellomoRinaldo @alebelletti1 h
RT @drhalat: Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Orga…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - The Lancet https://t.co/eNVKNluPkt
@screamingmd Largest study to date 1000+ patients courtesy of @ELSOOrg https://t.co/WOUq6mKgIM 61% survival to hospital discharge
RT @psehgal89: @screamingmd Lancet: https://t.co/fFMPp1l1AU 1035 patients analyzed (90 days) - 37% mortality - 30% discharged to home or r…
RT @psehgal89: @screamingmd Lancet: https://t.co/fFMPp1l1AU 1035 patients analyzed (90 days) - 37% mortality - 30% discharged to home or r…
@screamingmd Lancet: https://t.co/fFMPp1l1AU 1035 patients analyzed (90 days) - 37% mortality - 30% discharged to home or rehabilitation -10% to LTC; 17% another hospital - 6% still hospitalized EOLIA (2018): 35% mortality Definitely not futile in the
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/RnuKWRePtk
What outcomes can be expected in COVID-19 patients treated with ECMO? https://t.co/gTlpzqRZuK Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/ajerK16v2s
RT @LuisZuritaG: Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support…
Una opción en centros especializados. Muy cerca nuestro. Bucaramanga. Pero por favor que vaya quien lo necesita.
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/Oj7kNBygA8
Excited to tune into Medicine Grand Rounds today and learn more about ECMO and Lung Transplantation for COVID-19 patients! Check out these articles published in @TheLancet on ECMO and Lung Transplantation for COVID patients. https://t.co/CYOOMKHm42 https:
RT @McneillGregor: Thanks again to @DrJohnLivesey for presenting the recent ELSO registry paper at today’s SES CC Journal Club and thanks…
RT @McneillGregor: Thanks again to @DrJohnLivesey for presenting the recent ELSO registry paper at today’s SES CC Journal Club and thanks…
Thanks again to @DrJohnLivesey for presenting the recent ELSO registry paper at today’s SES CC Journal Club and thanks also to Dr Ian Scott from our National VV Ecmo Centre in @AberdeenICUEdu for joining us to discuss the paper #ecmo #ecls https://t.co
RT @CannessonMaxime: Data from 213 hospitals worldwide. @DrVadimG @UCLAAnes Extracorporeal membrane oxygenation support in COVID-19: an int…
RT @CannessonMaxime: Data from 213 hospitals worldwide. @DrVadimG @UCLAAnes Extracorporeal membrane oxygenation support in COVID-19: an int…
#COVID19 pts (>1000 pts from >200 hospitals) who received #ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or discharge were less than 40% @atscommunity @accpchest @ESICM @SCCM #MedTwitter h
RT @Gas_Craic: ECMO during #COVID19 is an evolving area of research, with more data coming soon. https://t.co/vecLu5ZFvA
RT @Gas_Craic: ECMO during #COVID19 is an evolving area of research, with more data coming soon. https://t.co/vecLu5ZFvA
ECMO during #COVID19 is an evolving area of research, with more data coming soon. https://t.co/vecLu5ZFvA
RT @ChristosArgyrop: @adamcifu 90 day survival data from ELSO were published last week https://t.co/NXmfD67MkQ We can always push the time…
RT @medpedshosp: Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - The Lancet https://t.co/YQ2gFRhC44
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - The Lancet https://t.co/GC4LBwlfBo
>60% survival at 90 days in COVID-19 patients (n=1035) who received ECMO therapy. From @ELSOOrg registry. - 80% of all patients had ARDS. - Only 7% had primary cardiac issues - 5% had cardiac arrest before ECMO initiation. @TheLancet https://t.co/
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support Organization registry: https://t.co/23aaRs2Ot0
@DafyddSiencyns
ECMO in COVID study of the @ELSOOrg registry: both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or discharge were less than 40% @foamecmo @pkguru10 https://t.co/wSS8ld1rx9 https://t.co/hEOLqprdT1
RT @TheLancet: NEW Research—Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Li…
RT @TheLancet: NEW Research—Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Li…
@MattMitovich @JeriLRyan Pure Speculation: with POTUS' physician's squirrely answers about whether Trump has been on supplemental oxygen, I present ECMO as a way to (poorly) dance around that question. https://t.co/O2guOfmUoG
Speculation: with POTUS' physician's squirrely answers about whether Trump has been on supplemental oxygen, I present ECMO as a way to (poorly) dance around that question. https://t.co/O2guOfmUoG
Interesante, la oxigenación por membrana extracorpórea (ECMO) en pacientes graves de COVID, una técnica con décadas detrás, que podría ser beneficiosa para determinados pacientes. 👍 🔗 The Lancet: https://t.co/rHrvIld6JH
A new #COVID19 publication from @UUtah researchers! Check it out: Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/us5oQJ6hAQ @UofUResearch @UofUH
@MThallinger @auduner @HalSandberg @Roar_Spurs Fra ELSO registeret er median tid på ECMO ved COVID 13,9 dager (IQR 7,8-23,3). https://t.co/xnUAVDuzi5
@MThallinger @HalSandberg @Roar_Spurs Men dødeligheten hos de som blir lagt på ECMO (bla på grunn av komplikasjoner som hjerneblødning) er jo betydelig (minst 37% basert på denne artikkelen fra ELSO https://t.co/xnUAVDuzi5 ), så jeg tenker det blir feil å
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - PubMed #ncbi https://t.co/2VO8Dw0kFr
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
@adamcifu 90 day survival data from ELSO were published last week https://t.co/NXmfD67MkQ We can always push the time limit to 6-9 month, but then we should have a broader convo about what critical care accomplishes, in general and whether we can predict t
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
RT @atscommunity: Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support…
Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Life Support Organization registry: https://t.co/23aaRs2Ot0
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @TheLancet: NEW Research—Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Li…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - The Lancet https://t.co/r4rKtEiZVu
RT @ArborMetrix: Important registry-based research from our partners at @ELSOOrg #clinicalregistries #clinicalresearch https://t.co/ArtVWb1…
Important registry-based research from our partners at @ELSOOrg #clinicalregistries #clinicalresearch
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/rHpTOy5qNK
RT @ELSOOrg: #ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/a…
#ECMO last-resort life support option helped majority of critically Ills #COVID19 patients survive @MHealthLab https://t.co/aEtq7vV0a9 Also, in this video @ECMO_Bob & @RyanPBarbaro on #ECLS in #SARSCoV2 https://t.co/Ey0LQgfIcc Full @TheLancet articl
ECMO support in #COVID19 patients. Of 1035 patients age 16 or older mortality was 39% - similar to past reports of ECMO-supported patients, with other forms of ARDS or pneumonia #MedTwitter @ELSOOrg @TheLancet https://t.co/0QvLGUhKCa
Patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or discharge were <40%. Data from 213 hospitals worldwide provide a generalisable estimate of ECMO mortality i
Multiple major health organisations recommend the use of extracorporeal membrane oxygenation (ECMO) support for COVID-19-related acute hypoxaemic respiratory failure.
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry https://t.co/CGM5Gzs0pZ @TheLancet #COVID19ECMO
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry - The Lancet https://t.co/orIvWIcb3S
RT @GermHunterMD: Remarkably good outcomes with ECMO for the sickest patients with COVID19! This registry included 1035 COVID19 patients…
>1000 #covid19 patients (median age 49y) were treated with #ECMO in these 200 hospitals around the world. The Lancet https://t.co/lBfek1SIUP
@wszczeklik Pan juz pewnie czytal, ale na wszelki wypadek podaje: https://t.co/etbLF8YTds
RT @TheLancet: NEW Research—Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Li…
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry #COVID19 https://t.co/3I1cgjEFpL
RT @MooreElizabethA: Important decision-making should be guided by science & data. It will be vital for #ECMO centers to stay informed if/…
Sobre ECMO y COVID19. Registro ELSO, 36 países, > 16a 1035 pacientes manejados con ECMO Mortalidad a 90 días < 40%.
RT @GermHunterMD: Remarkably good outcomes with ECMO for the sickest patients with COVID19! This registry included 1035 COVID19 patients…
#ECMO for #COVID19 patients... #FOAMed #FOAMcc https://t.co/dweEqTobEY
RT @TheLancet: NEW Research—Extracorporeal membrane oxygenation support in #COVID19: an international cohort study of the Extracorporeal Li…
RT @MooreElizabethA: Important decision-making should be guided by science & data. It will be vital for #ECMO centers to stay informed if/…
#ECMO in #Covid_19: key outcome and risk factor insights from the #ELSO registry in @TheLancet, expanding on the prior #EuroELSO data reported by Marullo et al https://t.co/PI2iATBdLf https://t.co/x8oIADEERv https://t.co/9zgwltUOJx
RT @MooreElizabethA: Important decision-making should be guided by science & data. It will be vital for #ECMO centers to stay informed if/…
RT @GermHunterMD: Remarkably good outcomes with ECMO for the sickest patients with COVID19! This registry included 1035 COVID19 patients…
RT @MooreElizabethA: Important decision-making should be guided by science & data. It will be vital for #ECMO centers to stay informed if/…
RT @MooreElizabethA: Important decision-making should be guided by science & data. It will be vital for #ECMO centers to stay informed if/…
RT @GermHunterMD: Remarkably good outcomes with ECMO for the sickest patients with COVID19! This registry included 1035 COVID19 patients…
RT @GermHunterMD: Remarkably good outcomes with ECMO for the sickest patients with COVID19! This registry included 1035 COVID19 patients…